• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ATRIUM MEDICAL FLIXENE GRAFT; PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ATRIUM MEDICAL FLIXENE GRAFT; PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER Back to Search Results
Model Number 25137
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Occlusion (1984)
Event Date 10/06/2018
Event Type  Injury  
Manufacturer Narrative
A follow up report will be submitted upon the completion of the investigation into this event.
 
Event Description
The patient was implanted the flixene (short-tapered) developed vascular occlusion and has been receiving percutaneous transluminal angioplasty repeatedly.The first vascular occlusion occurred at the anastomosis area on the arterial side, and then, also occurred at the anastomosis area on the venous side.This is the first avg for the patient.
 
Manufacturer Narrative
Based on the review of the device history records and product complaint details atrium can find no fault with the device in question.It is possible that the graft was placed to high within the elbow causing the blood flow to stop when the elbow was bent.Clinical evaluation - an arterio-venous (av) graft is a looped, synthetic tube that connects an artery to a vein.An av graft is a patient¿s lifeline.It is their best option for hemodialysis.Dialysis patients are already in a compromised state of health.It is imperative that the integrity of the graft not be compromised.Grafts are implanted surgically via an open incision and/or sub-cutaneous tunneling in certain applications.Surgeons undertaking such procedures are specialists and have the skills necessary to be working in an operative suite and are supported by trained staff.Even in that advent situations may arise that may be reasonably expected and appropriate intervention may need to be performed, such as bypassing a damaged graft.The risk to the patient becomes those risks associated with a prolonged procedure, pain or the potential of injury to surrounding tissue.The patient population that needs a vascular graft usually has pre-existing risk factors for thrombosis including coagulopathies, smoking, hypertension and dyslipidemia.Long term patency of the graft post intervention to correct an occlusion may be due to those very risks.Flixene vascular grafts are intended for use in arterial vascular reconstruction, segmental bypass, and for arteriovenous vascular access.Patency of a graft ensures the continuation of blood flow to an extremity or organ.If a graft loses patency it can be the cause of ischemia, thrombosis, tissue death and loss.Patency may be affected by any number of occurrences including progression of pre-existing vascular disease, thrombosis formation.The instructions for use (ifu) states complications that may occur in connection with the use of any vascular graft include, but are not limited to, thrombosis, formation of pseudo-aneurysm due to excessive, localized, multiple and/or large needle punctures, perigraft hematoma formation, perigraft seroma formation or ultrafiltration, excessive needle hole bleeding or weeping, infection, swelling of tissue, suture hole elongation, mechanical disruption, material separation, delamination or tearing of the graft material, suture line or host vessel which may result in extreme blood loss, loss of limb function, loss of limb or possible death.
 
Event Description
N/a.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FLIXENE GRAFT
Type of Device
PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER
Manufacturer (Section D)
ATRIUM MEDICAL
40 continental blvd
merrimack NH 03054
Manufacturer (Section G)
ATRIUM MEDICAL
40 continental blvd
merrimack NH 03054
Manufacturer Contact
40 continental blvd
merrimack, NH 03054
MDR Report Key8192389
MDR Text Key131300593
Report Number3011175548-2018-01521
Device Sequence Number1
Product Code DSY
UDI-Device Identifier00650862251371
UDI-Public00650862251371
Combination Product (y/n)N
PMA/PMN Number
K071923
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 12/21/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date04/03/2021
Device Model Number25137
Device Catalogue Number25137
Device Lot Number430200
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/07/2018
Initial Date FDA Received12/21/2018
Supplement Dates Manufacturer Received12/30/2018
Supplement Dates FDA Received01/07/2019
Was Device Evaluated by Manufacturer? No
Date Device Manufactured04/04/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-